Ayala Pharmaceuticals, Inc. reports

Company location: Monmouth Junction, NJ
Fiscal year end: 31 December

Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 376-400 of 1,000 matching filings.

Per page

25

Current page

16

PRE 14A File 001-36138

PRE 14A filing

Filing date: 25 Jan 2018
Reporting date: 25 Jan 2018
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-222483

S-8 filing

Filing date: 09 Jan 2018
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Jan 2018
Reporting date: 29 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 03 Jan 2018
Reporting date: 29 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-36138

10-K filing

Filing date: 21 Dec 2017
Reporting date: 31 Oct 2017
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 20 Dec 2017
Reporting date: 20 Dec 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Dec 2017
Reporting date: 30 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Dec 2017
Reporting date: 30 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-80101

SC 13G/A filing

Filing date: 09 Nov 2017
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 06 Nov 2017
Reporting date: 02 Nov 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Nov 2017
Reporting date: 31 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Nov 2017
Reporting date: 31 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Nov 2017
Reporting date: 31 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

ADAGE CAPITAL PARTNERS, GP L.L.C.

Filing date: 12 Oct 2017
Reporting date: 11 Oct 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Oct 2017
Reporting date: 29 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Oct 2017
Reporting date: 29 Sep 2017
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .